Tmd Clinical Trials
Here is the most popular medical study for tmd
Popular filter options for tmd trials
TMJ Clinical Trials
View 7 TMJ medical studies.
Behavioural Intervention
Physical Self Regulation Telehealth +1 More for Temporomandibular Joint Disorder
This trial will include patients with chronic jaw muscle pain who will be randomly assigned to receive a behavioral intervention called Physical Self-Regulation or a control intervention. Both interventions will be conducted remotely via telehealth
Behavioral Intervention
Individualized Treatment for TMJ Dysfunction
This trial is testing a new, individualized treatment for TMD that could be more effective than other psychosocial treatments. The goal is to also discover the mechanisms by which psychosocial treatments work in chronic pain.
Radiofrequency
TMD Pulsed Radiofrequency for Temporomandibular Joint Pain
PRF of the masticatory muscles (masseter, temporalis, medial and lateral pterygoid muscle) can improve pain intensity and functional recovery of the jaw in patients with extra-articular TMD.
Temporomandibular Joint Disorder Clinical Trials
View 6 Temporomandibular Joint Disorder medical studies.
Behavioural Intervention
Physical Self Regulation Telehealth +1 More for Temporomandibular Joint Disorder
This trial will include patients with chronic jaw muscle pain who will be randomly assigned to receive a behavioral intervention called Physical Self-Regulation or a control intervention. Both interventions will be conducted remotely via telehealth
Behavioral Intervention
Individualized Treatment for TMJ Dysfunction
This trial is testing a new, individualized treatment for TMD that could be more effective than other psychosocial treatments. The goal is to also discover the mechanisms by which psychosocial treatments work in chronic pain.
Frequently Asked Questions
Introduction to tmd
What are the top hospitals conducting tmd research?
When it comes to clinical trials focused on temporomandibular disorders (TMD), several top hospitals are at the forefront of research and innovation. The University of Florida in Gainesville stands out with two active TMD trials, marking their dedication to understanding and treating this condition. While they have only recorded two TMD trials thus far, their involvement began as recently as 2021, showcasing their commitment to exploring new avenues for patients suffering from TMD. UConn Health in Farmington is another notable institution making strides in TMD research with two ongoing clinical trials. Their first recorded trial also took place in 2021, demonstrating a fresh approach to addressing this complex disorder.
In Boston, the Massachusetts Eye and Ear Infirmary has emerged as a leader in tackling TMD through its innovative clinical trial efforts. Though currently conducting just one active trial pertaining to this disorder, the institution's commitment is evident by initiating its inaugural study in 2022. Similarly dedicated is the Indiana University School of Dentistry's Oral Health Research Institute located in Indianapolis, which has one ongoing TMD trial alongside an impressive history of one completed study since launching its first investigation into TMD back in 2021.
Lastly but certainly not least important is Luana Colloca facility based within Baltimore whose importance lies beyond that; even though involved once again solely performing single current tmd-focused experiment while maintaining similar track record when compared against previously mentioned institutions—having initiated exploration processes revolving around these debilitating conditions exclusively starting from year twenty-twenty-one.
These leading hospitals exemplify the collaborative efforts taking place across different regions within our healthcare system to shed light on temporomandibular disorders. By investing time and resources into these vital studies today, we lay the foundation for better diagnosis methods and treatment options tomorrow—ultimately offering hope and relief for individuals living with chronic jaw pain or dysfunction caused by TMD-related issues.
Which are the best cities for tmd clinical trials?
When it comes to TMD clinical trials, several cities have emerged as leaders in research and development. Gainesville, Florida, offers 2 active trials that focus on interventions like Active PBM and the THOR® laser system. Farmington, Connecticut, also boasts 2 ongoing studies investigating innovative approaches such as the painTRAINER pain management web application and an Individualized Assessment and Treatment Program. Lastly, Boston, Massachusetts; Indianapolis, Indiana; and Baltimore, Maryland each have 1 active trial exploring different aspects of TMD diagnosis and treatment. These cities provide individuals with opportunities to participate in cutting-edge clinical trials aimed at improving our understanding of TMD and developing more effective treatments.
Which are the top treatments for tmd being explored in clinical trials?
In the realm of Temporomandibular Disorders (TMD), one treatment stands out in ongoing clinical trials: DystoniaNet-based diagnosis of isolated dystonia. This innovative approach is currently being tested in one active trial, marking its first appearance in TMD research listings in 2022. While it may be early days for this particular treatment, its potential impact on TMD patients holds promise and warrants further investigation. As researchers delve deeper into understanding TMD, advancements like DystoniaNet-based diagnosis offer hope for improved diagnostics and management strategies to alleviate the burden of this condition.
What are the most recent clinical trials for tmd?
Recent clinical trials have brought promising developments in the field of temporomandibular disorder (TMD) treatment. Arm A, a Phase 2 trial, has shown potential benefits for individuals with TMD. Additionally, the Natural History study, which encompasses both Phase 1 and Phase 2, aims to better understand the progression and outcomes of TMD. Another notable trial investigated the effectiveness of the THOR® laser system as a therapeutic intervention for TMD. These studies offer hope for improved management and relief for those affected by this condition.
What tmd clinical trials were recently completed?
A recent clinical trial investigating the potential of Botulinum toxin type A in treating temporomandibular disorder (TMD) was successfully completed in August 2018. Sponsored by Weill Medical College of Cornell University, this study has provided valuable insights into the effectiveness and safety of this treatment approach for TMD patients. While more research is needed to fully understand its benefits, these findings offer a promising avenue for addressing the challenges faced by individuals with TMD.